Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
about
Epstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.Serological diagnosis of Epstein-Barr virus infection: Problems and solutionsCross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymersEpstein-Barr virus and cytomegalovirus infections and their clinical relevance in Egyptian leukemic pediatric patients.Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis.New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipientsThe role of EBV in post-transplant malignancies: a review.A new method with general diagnostic utility for the calculation of immunoglobulin G avidityEvaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodiesEvaluation of an immunochromatographic assay for the detection of anti-hepatitis A virus IgM.Clinical characteristics of patients with Epstein Barr virus in cerebrospinal fluid.Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study.The expanding realm of heterologous immunity: friend or foe?Is there diagnostic value in detection of immunoglobulin g antibodies to the epstein-barr virus early antigen?The impact of serological features in Chinese children with primary or past Epstein-Barr virus infections.Immunoglobulin M for Acute Infection: True or False?Evaluation of an immunofiltration assay that detects immunoglobulin M antibodies against the ZEBRA protein for the diagnosis of Epstein-Barr virus infectious mononucleosis in immunocompetent patientsEpstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells.Diagnostic relevance of immunoglobulin G avidity for hepatitis A virusMaternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring.Comparison of three automated immunoassay methods for the determination of Epstein-Barr virus-specific immunoglobulin M.Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.Malignancies after heart transplantation: presence of Epstein-Barr virus and cytomegalovirus.Viral Impact in Autoimmune Diseases: Expanding the "X Chromosome-Nucleolus Nexus" Hypothesis.
P2860
Q24798984-38642C5D-C175-43F9-9A93-10975CE39AE5Q26829346-1BD1675D-BAA3-4988-ADE7-0887318613C2Q28367797-91955355-E5E9-4049-B7E7-336FBC872150Q33439883-7DE00610-17FF-4338-B9DA-40BA1F27A92AQ33743467-033C9A7B-EE56-4807-BA09-43793204BC4AQ33812425-3F985BE6-15A4-4E81-B005-2D9151A0D229Q33925488-BCACE320-EE17-4DD7-8417-FFAEED3C4BF1Q33997895-31781633-38C3-43B6-B582-C45049C5E6D9Q33998379-4233270B-38C6-487D-A110-E73BD38C8E9EQ34039358-22596ABC-418F-4EA5-B196-D43401D68816Q34054002-4C564206-B24E-4ED9-B20E-F47C7EC70D41Q34548374-9A0327EB-DB7B-4B66-8D52-D2C8DA547D7AQ36379481-266D98E0-063D-462C-8785-2067886347D4Q36574561-5F555760-CBE3-4596-86DD-0AADF429990FQ36687519-AAA377A9-8D5B-4D08-9918-B8788C66AB2DQ37067278-6EC6B5D4-713C-44FC-A080-4130DF13E33DQ37213859-845CD269-F57D-4A8C-9C3B-23CA9F4D1A9EQ37336791-D2B58721-CEC1-43C7-83B8-6D35C63EF6B3Q37597413-26B33276-7D1B-471E-AA6F-93D6F8584282Q39179697-717CCCAA-1CF1-4DA6-9D69-F28073344AE0Q39894657-1AB3F74D-CEB2-434F-9F44-2D1C8186E1B7Q40333194-50B4C2C2-410F-426E-A917-4259307BC02AQ45735035-DA253367-630E-4042-9BA6-E33598038D2EQ47151158-79A1A992-6FC7-4881-81AC-08ECD52A9EDB
P2860
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
@en
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
@nl
type
label
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
@en
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
@nl
prefLabel
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
@en
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
@nl
P2093
P1476
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
@en
P2093
Linnavuori K
Schubert J
Weissbrich B
P304
P356
10.1002/(SICI)1096-9071(199811)56:3<186::AID-JMV2>3.3.CO;2-N
P50
P577
1998-11-01T00:00:00Z